- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Ticlopidine is a cardiovascular drug used to reduce the risk of stroke in people with certain types of heart disease. It is an antiplatelet drug, meaning it works by preventing platelets from clumping together and forming clots that can block blood vessels. It is usually prescribed in combination with aspirin and other medications. Ticlopidine is used to reduce the risk of stroke in people with atrial fibrillation, a type of irregular heartbeat, and in people who have had a stroke or transient ischemic attack (TIA). It is also used to reduce the risk of stroke in people who have had a heart attack or coronary artery bypass graft (CABG) surgery.
Ticlopidine is available in both generic and brand-name forms. It is available as a tablet, capsule, and oral suspension. Common side effects of ticlopidine include nausea, vomiting, diarrhea, and abdominal pain. More serious side effects include low white blood cell count, liver damage, and bleeding.
Some companies in the ticlopidine market include Mylan, Teva Pharmaceuticals, and Sandoz. Show Less Read more